R. Trevisan et al., ENHANCED GROWTH AND NA+ H+ ANTIPORT ACTIVITY RESPONSE TO SERUM IN CULTURED FIBROBLASTS OF DIABETIC-PATIENTS WITH NEPHROPATHY/, Acta diabetologica, 29(3-4), 1992, pp. 178-181
To explore whether elevated red blood cell sodium-lithium countertrans
port in type 1 (insulin-dependent) diabetic patients with nephropathy
is related to the physiological Na+/H+ antiport activity, we measured
the activity of this antiport in serially passaged cultured skin fibro
blasts from insulin-dependent diabetic patients with and without nephr
opathy and from non-diabetic controls. Na+/H+ antiport activity (measu
red as the rate of amiloride-sensitive Na+ influx) was significantly e
levated in patients with nephropathy compared with patients without ne
phropathy and normal controls (13.35 +/- 3.8 vs 8.54 +/- 2.0 vs 7.33 /- 2.3 nmol Na+/mg protein per min; P < 0.006 and P < 0.001 respective
ly). This raised activity in patients with nephropathy was due to an i
ncreased V(max) for extracellular Na+. K(m) values were similar in the
three groups. Amiloride-sensitive Na+ influx was also higher in cells
under baseline conditions and after serum stimulation from patients w
ith nephropathy. Intracellular pH values were significantly higher, bo
th during active proliferation and after 10 min of exposure to serum,
in cells from patients with nephropathy compared with patients without
nephropathy and normal controls. Serum-stimulated incorporation of [H
-3]thymidine into DNA was greater in patients with nephropathy than in
the other two groups. These data in cultured fibroblasts suggest that
intrinsic abnormalities in cell function, independently of the metabo
lic disturbances of diabetes, are a feature of diabetic patients who d
evelop nephropathy.